|
Synonyms: MLTA3698A | PRO283698 | RG7416
Compound class:
Antibody
Comment: Pateclizumab is a humanized anti-lymphotoxin alpha (LTA) monoclonal antibody that is being investigated for anti-inflammatory potential. Peptide sequences for the heavy and light chains of pateclizumab are 100% matches to sequences 106 and 107 that are claimed in Genentech's patent US7923011B2 [1]. Sequences 106 and 107 identify pateclizumab as antibody 2C8.vX as defined in the patent.
|
Classification  |
|
| Compound class | Antibody |
| International Nonproprietary Names |
|
| INN number | INN |
| 9428 | pateclizumab |
| Synonyms |
| MLTA3698A | PRO283698 | RG7416 |
| Database Links |
|
| Specialist databases | |
| IMGT/mAb-DB | 383 |
| Other databases | |
| GtoPdb PubChem SID | 363894148 |
| Search PubMed clinical trials | pateclizumab |
| Search PubMed titles | pateclizumab |
| Search PubMed titles/abstracts | pateclizumab |
